Cancer Causes & Control

, Volume 16, Issue 9, pp 1055–1058 | Cite as

Prostate Cancer Risk Among Men with Diabetes Mellitus (Spain)

Article

Abstract

Objective: Observational studies have associated diabetes with a decreased risk of prostate cancer. We aimed to evaluate this association using the General Practitioner Research Database in the UK.

Methods: Population based case–control study nested in a cohort.

Results: We identified 2,183 incident cases of prostate cancer between January 1995 and December 2001. We found that diabetic patients had a decreased risk of prostate cancer (OR = 0.72; 95% CI: 0.59–0.87). This association was observed among treated diabetics (OR = 0.63; 95% CI: 0.50–0.80) but not among untreated diabetics (OR = 1.01; 95% CI: 0.73–1.40). Our results suggest that the observed reduced risk could be restricted to users of insulin or sulphonylureas.

Conclusion: Patients with diabetes have a decreased risk of prostate cancer. The role of antidiabetic treatment in this association warrants further research.

Keywords

diabetes mellitus epidemiologic studies prostate cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bonovas, S, Filioussi, K, Tsantes, A 2004Diabetes mellitus and risk of prostate cancer: a meta-analysisDiabetologia4710718CrossRefPubMedGoogle Scholar
  2. 2.
    Coffey DS (1979) Physiological control of prostatic growth: an overview. In: Prostate Cancer. International Union Against Cancer. UICC Technical Report Series, Vol 48. Geneva, pp. 4–23Google Scholar
  3. 3.
    Gann, PH, Hennekens, CH, Ma, J, Longcope, C, Stampfer, MJ 1996Prospective study of sex hormone levels and risk of prostate cancerJ Natl Cancer Inst8811181126PubMedGoogle Scholar
  4. 4.
    Hovenanian, MS, Deming, CL 1948The heterologous growth of cancer of the human prostateSurg Gynecol Obstet862935Google Scholar
  5. 5.
    Ando, S, Rubens, R, Rottiers, R 1984Androgen plasma levels in male diabetesJ Endocrinol Invest72124PubMedGoogle Scholar
  6. 6.
    LeRoith, D, Baserga, R, Helman, L, Roberts, CT 1995Insulin-like growth factors and cancerAnn Intern Med122 5459PubMedGoogle Scholar
  7. 7.
    Stattin, P, Rinaldi, S, Biessy, C, Stenman, UH, Hallmans, G, Kaaks, R 2004High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohortJ Clin Oncol2231043112CrossRefPubMedGoogle Scholar
  8. 8.
    Suikkari, AM, Koivisto, VA, Rutanen, EM, Yki-Jarvinen, H, Karonen, SL, Seppala, M 1988Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding proteinJ Clin Endocrinol Metab66266272PubMedGoogle Scholar
  9. 9.
    Orskov, H 1996Somatostatin, growth hormone, insulin-like growth factor-1, and diabetes: friends or foes?Metabolism459195CrossRefPubMedGoogle Scholar
  10. 10.
    García Rodríguez, LA, Pérez Gutthann, S 1998Use of the U.K. General Practice Research Database for pharmacoepidemiologyBr J Clin Pharmacol45419426CrossRefPubMedGoogle Scholar
  11. 11.
    Jick, H, Jick, SS, Derby, LE 1991Validation of information recorded on general practitioner based computerised data resource in the United KingdomBMJ302766768PubMedGoogle Scholar
  12. 12.
    García Rodríguez, LA, González-Pérez, A 2004Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancerCancer Epidemiol Biomar Prev13649653Google Scholar
  13. 13.
    Ronquist, G, García Rodríguez, LA, Ruigómez, A,  et al. 2004Association between captopril, other antihypertensive drugs and risk of prostate cancerProstate585056CrossRefPubMedGoogle Scholar
  14. 14.
    Zhu, K, Lee, IM, Sesso, HD, Buring, JE, Levine, RS, Gaziano, JM 2004History of diabetes mellitus and risk of prostate cancer in physiciansAm J Epidemiol159978982CrossRefPubMedGoogle Scholar
  15. 15.
    Coker, AL, Sanderson, M, Zheng, W, Fadden, MK 2004Diabetes mellitus and prostate cancer risk among older men: population-based case-control studyBr J Cancer90 21712175PubMedGoogle Scholar
  16. 16.
    Coughlin, SS, Calle, EE, Teras, LR, Petrelli, J, Thun, MJ 2004Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adultsAm J Epidemiol15911601167CrossRefPubMedGoogle Scholar
  17. 17.
    Joint Health Surveys Unit1999Health Survey for England 1998The Stationery OfficeLondonGoogle Scholar
  18. 18.
    Hippisley-Cox, J, Pringle, M 2004Prevalence, care, and outcomes for patients with diet-controlled diabetes in general practice: cross sectional surveyLancet364423428CrossRefPubMedGoogle Scholar
  19. 19.
    Rosenberg, DJ, Neugut, AI, Ahsan, H, Shea, S 2002Diabetes mellitus and the risk of prostate cancerCancer Invest20157165CrossRefPubMedGoogle Scholar
  20. 20.
    DeFronzo, RA 1999Pharmacologic therapy for type 2 diabetes mellitusAnn Intern Med131281303PubMedGoogle Scholar
  21. 21.
    Scheen, AJ, Lefebvre, PJ 1998Oral antidiabetic agents. A guide to selectionDrugs55225236PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  1. 1.Centro Español de Investigación Farmacoepidemiológica (CEIFE)MadridSpain

Personalised recommendations